Page results
-
UCLH Charity is delighted to announce a generous £1.5 million donation from the Bukhman Philanthropies.
-
The artist Caroline Walker, whose work was featured in The Guardian at the weekend, created some of the paintings being shown in her current solo exhibition, during an artist residency at UCLH in 2021.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Update about our hospital on Gray's Inn Road
-
The information provided aims to address the questions you may have about surgical management of endometriosis.
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
We’re delighted to announce that our Grafton Way Elective Surgical Hub has been successfully accredited as an elective surgical hub delivering high standards in clinical and operational practice.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
File results
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images